Connor, Clark & Lunn Investment Management »

Lenz Therapeutics shares owned by Connor, Clark & Lunn Investment Management

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Connor, Clark & Lunn Investment Management from 13F filings

Historical chart of Connor, Clark & Lunn Investment Management investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Connor, Clark & Lunn Investment Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $341k 37k 9.15

More positions owned by Connor, Clark & Lunn Investment Management

Rbc Cad (RY)
Agnico (AEM)
Toronto Dominion Bk Ont Com New (TD)
Suncor Energy (SU)
Enbridge (ENB)
NVIDIA Corporation (NVDA)
Cibc Cad (CM)
Tc Energy Corp (TRP)
Apple (AAPL)
Shopify Cl A Sub Vtg Shs (SHOP)
Bk Nova Cad (BNS)
Invesco Exch Traded Fd Tr Ii Purbta Msci Us (PBUS)
Canadian Pacific Kansas City (CP)
Microsoft Corporation (MSFT)
Amazon (AMZN)

View all positions for Connor, Clark & Lunn Investment Management

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
FMR
Versant Venture Management
BlackRock
Squarepoint Ops
Vanguard Group
Standard Life Aberdeen
Franklin Resources
Vanguard Capital Management
72 Investment Holdings
Millennium Management
CAM Group Holding A/S
Morgan Stanley
Bank of America Corporation

View all funds holding Lenz Therapeutics